Background: Rates of drug use in Nigeria is one of the highest globally, with the use of opioids associated with increased morbidity and mortality more so with injecting drug use (IDU). MAT) can reduce the harmful effects of opioid use but usage in the country is low despite a country-specific guideline in place. A notable barrier to MAT uptake is professionals' knowledge and attitudes. This study aimed to evidence the opinions of Substance use professionals (SUPs) in Nigeria regarding MAT.
Objective: To ascertain the opinions of SUPs in Nigeria regarding MAT prescriptions for opioid dependence.
Methods: An online Google form was developed by the researchers to assess knowledge and attitudes towards MAT. This form was circulated among SUPs across the six geopolitical zones and the capital territory in Nigeria.
Results: Three hundred and twenty-nine professionals completed the questionnaire. Most were medical doctors (53.8%) and worked in the public sector (89%). Average work experience was 11 years and respondents estimated that nearly 1 in 10 OUD patients they cared for were IDUs. A majority (85.7%) endorsed the need for MAT in Nigeria, though had no previous experience (65.3%), training (74.2%) or knowledge of existing guidelines (68.7%). Over half (55%) endorsed a preference for the availability of buprenorphine and methadone. Most endorsed positive attitudes towards MAT prescriptions.
Conclusion: Substance use professionals endorsed positive attitudes towards MAT for OUDs and its rollout in Nigeria. Awareness of published guidelines and training are unmet needs arising from this study. Keywords: Medical assisted treatment (MAT), opioid use disorders, opinion and experiences.
Download full-text PDF |
Source |
---|
J Addict Med
January 2025
From the Department of History, University of Rochester, Rochester, NY (MR); Department of Medicine, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY (MR); Columbia Law School, New York, NY (JG-K); and Section of Child Safety, Advocacy & Healing, Department of Pediatrics, Yale School of Medicine, New Haven, CT (AGA).
The decriminalization of tetrahydrocannabinol (THC)-containing products has resulted in an increased presence of these products in households. This increased presence, along with frequent use of product packaging that mimics recognizable and appealing treats, has led to a rise in accidental ingestions of THC-containing substances by children. Some clinicians and child protective services (CPS) professionals have recommended that every accidental THC ingestion by a child, irrespective of the circumstances, should be reported for investigation by CPS.
View Article and Find Full Text PDFTijdschr Psychiatr
January 2025
Background: Pharmacotherapy is an effective treatment strategy for psychiatric disorders. Nevertheless, many patients discontinue their medication at some point. Evidence-based practices for patients, clinicians, and policymakers to discontinue psychotropic medication properly are therefore important.
View Article and Find Full Text PDFAlzheimers Dement (N Y)
December 2024
Introduction: The professional caregiver workforce (nursing assistants and personal care aides) is critical to quality of care and quality of life in nursing home (NH) and assisted living (AL) settings. The work is highly stressful, so improving responses to stress in this workforce could contribute to satisfaction and retention. This research developed a coping measure appropriate for the diverse professional caregiver workforce.
View Article and Find Full Text PDFAlzheimers Dement (N Y)
December 2024
Introduction: Professional caregivers (nursing assistants and personal care aides) in nursing homes (NH) and assisted living (AL) provide the majority of long-term residential care for persons with Alzheimer's disease and related dementias. Their work is stressful, but until recently, no measures were available to assess stress in this workforce. Using the new Long-Term Care Cope (LTC COPE) scale, this study evaluates the relationship of coping with staff demographic characteristics and outcomes; the findings can be used to develop and evaluate interventions to improve staff well-being.
View Article and Find Full Text PDFPsychopharmacol Bull
January 2025
Sychev, corresponding member of the Academy of Sciences of Russia, MD, PhD, MD, professor, rector, head of clinical pharmacology and therapy department, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Introduction: Alcoholic hallucinosis (AH) is one of the severe complications of chronic alcoholism, characterized by psychotic symptoms such as auditory hallucinations and delusions. Haloperidol is widely used to treat AH; however, its therapy is often complicated by side effects. A personalized approach using pharmacogenetic testing (particularly the CYP2D6 polymorphism) allows individualization of haloperidol dosage, improving both safety and efficacy of therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!